AI-generated analysis. Always verify with the original filing.
Catheter Precision, Inc. entered into Series J Exchange Agreements with David A. Jenkins and FatBoy Capital, LP to convert royalty rights and accrued royalty amounts totaling a net present value of $9,489,487.81 into 9,489.488 shares of newly created Series J Convertible Preferred Stock. The transaction settles existing obligations and provides for potential future conversion into common stock, subject to stockholder approval.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on From 8-K is hereby incorporated herein by reference. Item 7.01 Regulation FD Disclosure. On February 12, 2026, the Company issued a pr
Unregistered Sales of Equity Securities. All information set forth in Item 1.01 of this Current Report on Form 8-K is hereby incorporated herein by reference. I
(including Exhibit 99.1 hereto), is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amende
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Designation of Preferences, Rights and Limitations of Series J Conve
Material Agreement